Healthcare

News: Zosano Discontinues Novo Nordisk Venture $ZSAN

Healthcare, News /

Zosano Pharma Corporation has announced that Novo Nordisk has notified Zosano of its intention to discontinue the collaboration agreement related to development of a transdermal presentation of select NVO glucagon-like peptide-1 (GLP-1) analogues. Zosano has been notified that the decision relates to a strategic prioritization of NVO’s research portfolio despite continued progress during the collaboration […]

News: Zosano Discontinues Novo Nordisk Venture $ZSAN Read More »

News: Retrophin sold Priority Review Voucher to Sanofi $RTRX

Healthcare, News /

Retrophin, Inc. has announced the closing of the agreement to sell its Rare Pediatric Disease Priority Review Voucher to Sanofi Under the terms of the agreement, Retrophin has received a payment of $150 million, and will receive two additional payments of $47.5 million in 2016 and 2017. Retrophin also announced the prepayment of its $45 million

News: Retrophin sold Priority Review Voucher to Sanofi $RTRX Read More »

News: Synergy Adds Professionals to BOD $SGYP

Healthcare, News /

Synergy Pharmaceuticals Inc.has announced that it has appointed Timothy Callahan and Richard Daly as new independent directors to its board. Both Mr. Callahan and Mr. Daly have direct experience in primary care and gastrointestinal markets and have led large organizational change and successful business growth, in a variety of areas, including all aspects of commercial, acquisitions,

News: Synergy Adds Professionals to BOD $SGYP Read More »